NCT05377476

Brief Summary

It was planned to examine the effects of motor imagery and action observation applied in addition to standard rehabilitation in people with multiple sclerosis on walking, fatigue, and trunk control.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P50-P75 for not_applicable multiple-sclerosis

Timeline
Completed

Started Jun 2022

Typical duration for not_applicable multiple-sclerosis

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 12, 2022

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 17, 2022

Completed
15 days until next milestone

Study Start

First participant enrolled

June 1, 2022

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2024

Completed
Last Updated

December 19, 2025

Status Verified

December 1, 2025

Enrollment Period

1.8 years

First QC Date

May 12, 2022

Last Update Submit

December 15, 2025

Conditions

Keywords

Multiple SclerosisMotor ImageryAction ObservationWalkingFatigueTrunk Control

Outcome Measures

Primary Outcomes (1)

  • 6 Min Walking Test

    It will be used to measure walking distance. Before the test is administered, individuals will be given the necessary information and will be asked to walk as fast as possible on a 30-meter track for 6 minutes.

    6 week

Secondary Outcomes (5)

  • Timed Up and Go Test

    6 week

  • Multiple Sclerosis Walking Scale-12

    6 week

  • RehaGait® (Hasomed, Magdeburg, Germany) Gait Analysis

    6 week

  • Fatigue Severity Scale

    6 week

  • Trunk Impairment Scale

    6 week

Study Arms (3)

Motor Imagery Group

EXPERIMENTAL

Individuals included in this group will receive 20 minutes of motor imagery training in addition to 40 minutes of standard rehabilitation. Patients will be trained 3 days a week for 6 weeks.

Other: Motor Imagery trainingOther: standard rehabilitation

Action Observation Group

EXPERIMENTAL

Individuals included in this group will receive 20 minutes of action observation training in addition to 40 minutes of standard rehabilitation. Patients will be trained 3 days a week for 6 weeks.

Other: Action Observation trainingOther: standard rehabilitation

Control Group

OTHER

Individuals included in this group will receive only 40 minutes of standard rehabilitation. Patients will be trained 3 days a week for 6 weeks.

Other: standard rehabilitation

Interventions

Individuals included in this group will receive 20 minutes of motor imagery training in addition to 40 minutes of standard rehabilitation.

Motor Imagery Group

40 minutes of standard rehabilitation.

Action Observation GroupControl GroupMotor Imagery Group

Individuals included in this group will receive 20 minutes of action observation training in addition to 40 minutes of standard rehabilitation.

Action Observation Group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Being between the ages of 18-65
  • A definitive diagnosis of MS by a neurologist according to the 2017 McDonald Criteria
  • Expanded Disability Status Scale (EDSS) score of 4.0 and below (it is determined routinely by the physician during the examination)
  • Not having an attack in the last 3 months
  • A minimum score of 4 in each motor imagery ability (internal visual imagery, external visual imagery, and kinesthetic imagery) on the Movement Imagery Questionnaire-3 (MIQ-3)

You may not qualify if:

  • cognitive impairment, defined as a Mini-Mental State Examination (MMSE) score of less than 24
  • Having another musculoskeletal, cardiovascular, pulmonary, metabolic, or neurological disease severe enough to preclude participation in the study.
  • Having severe vision and hearing problems

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hacettepe University

Ankara, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Multiple SclerosisFatigue

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Melike Sumeyye Ozen, M.Sc.

    Bandırma Onyedi Eylül University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Assistant

Study Record Dates

First Submitted

May 12, 2022

First Posted

May 17, 2022

Study Start

June 1, 2022

Primary Completion

April 1, 2024

Study Completion

June 1, 2024

Last Updated

December 19, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Locations